Never miss a story

Get subscribed to our newsletter


×
According to the researchers, these novel findings may provide the basis for new therapies for patients who have heart disease complicated by diabetes. Pixabay

In a first, researchers have found that a treatment affecting the immune system effectively slowed the progression to clinical Type-1 diabetes in high risk individuals by two years or more.

“The results have important implications for people, particularly youth, who have relatives with the disease, as these individuals may be at high risk and benefit from early screening and treatment,” said Lisa Spain, Project Scientist from US National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).


The study, involving treatment with an anti-CD3 monoclonal antibody (teplizumab), was conducted by Type 1 Diabetes TrialNet, an international collaboration aimed at discovering ways to delay or prevent Type-1 diabetes.

Participants were randomly assigned to either the treatment group, which received a 14-day course of teplizumab, or the control group, which received a placebo.

All participants received glucose tolerance tests regularly until the study was completed, or until they developed clinical Type-1 diabetes – whichever came first.

During the trial, 72 per cent of the people in the control group developed clinical diabetes, compared to only 43 per cent of the teplizumab group.


“Although Type-1 and Type-2 diabetes in parents are well-established risk factors for diabetes, we show that gestational diabetes mellitus may be a risk indicator for diabetes in the mother’s children before age 22,” . Pixabay

The median time for people in the control group to develop clinical diabetes was just over 24 months, while those who developed clinical diabetes in the treatment group had a median time of 48 months before progressing to diagnosis.

“The difference in outcomes was striking. This discovery is the first evidence we’ve seen that clinical Type-1 diabetes can be delayed with early preventive treatment,” Spain added.

Type-1 diabetes develops when the immune system’s T cells mistakenly destroy the body’s own insulin-producing beta cells.

Also Read- Cutting Sodium Intake May Prevent 94 Million Premature Deaths From CVD

Insulin is needed to convert glucose into energy. Teplizumab targets T cells to lessen the destruction of beta cells.

The effects of the drug were greatest in the first year after it was given, said the study published online in The New England Journal of Medicine. (IANS)


Popular

Pixabay

God and Goddess

By- Devakinanda

OṀ KALMASHARAHITABHŨMYAI NAMAH:

Keep Reading Show less
Pixabay

Olympic game

By- Ewan

Xander Schauffele held off the late challenges from the chasing pack, none more so than Rory Sabbatini of Slovakia — who got without a single stroke of the American — to win a gold medal in the men's individual golf tournament at the Summer Olympic Games in Tokyo.

Keep Reading Show less
Pixabay

Needless to say that staying at home and learning are the biggest incompatibilities.

By- Kelly

Today, e-learning is one of the best alternatives for studying despite quarantine restrictions. Still, it has its own flaws, which are noticeable during the long-term experience. From one point, students learn to be independent and prepare their homework without extra help. Usually, everyone can buy essays for sale online and prepare for classes efficiently. And from the other point, online learning demands the highest responsibility. Let's find out why the face-to-face educational process is still more productive.

Keep reading... Show less